ClinicalTrials.Veeva

Menu

Diabetes and Metabolic Postprandial Responses

H

Human Nutrition Research Centers (CRNH)

Status

Completed

Conditions

Overweight
Type 2 Diabetes

Treatments

Other: oral glucose load

Study type

Interventional

Funder types

Other

Identifiers

NCT00767208
CRNHRA-06-002

Details and patient eligibility

About

The aim of this trial was to compare postprandial metabolic response to glucose load in healthy overweight and type 2 diabetic subjects, by using glycemia, insulinemia, lipid profile, nutrient oxidation follow-up. Stable isotopes of glucose were used to assess postprandial total,exogenous and endogenous glucose kinetics.

Sex

All

Ages

30 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Overweight or obese volunteers
  • Healthy for one group nd type 2 diabetic for the second group
  • Age between 30 and 65 years old
  • Total cholesterol < or = 7 mmol/l and triglycerides < or = 4 mmol/l
  • For diabetic group: treated by metformin and/or sulfonylurea and/or thiazolidinedione and HbA1c < 6%
  • Stable weight over last 3 months
  • Informed consent

Exclusion criteria

  • No compliant subjects
  • Participation in an other trial 2 months before starting this one
  • Ward of court or under guardianship (sheltered adults)
  • Person deprived of freedom by judicial or administrative decision
  • Type 1 diabetes and type 2 diabetes treated bu insulin or acarbose
  • Existence of a previously diagnosed pathology (other than type 2 diabetes)
  • Previous gastro-intestinal pathology
  • Treated by corticoids, anorexigens, weight loss medicines
  • Alcoholism or severe tobacco consumption

Trial design

24 participants in 2 patient groups

type 2 diabetic subjects
Experimental group
Treatment:
Other: oral glucose load
overweight healthy subjects
Experimental group
Treatment:
Other: oral glucose load

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems